Company intelligence
iOMEDICO
together, we IMPROVE ONCOLOGY
About iOMEDICO
iOMEDICO specializes in oncology clinical research We are experts and specialists in oncology and hematology, translating clinical questions into practical trial concepts to improve patient care. Together with our oncology network, we collect detailed clinical data from over 6000 new oncology patients each year. We are a full-service clinical research organization covering clinical phase I to IV studies, non-interventional studies and tumor registries. Our multidisciplinary team consists of highly qualified professionals, such as clinical oncologists, research scientists, biostatisticians and medical writers. together, we IMPROVE ONCOLOGY iOMEDICO started in 1993 by programming one of the first electronic data capture (EDC) systems with the aim of collecting clinical data in a timely, quality-managed and paperless manner. Today, we research new substances and treatment options in cooperation with over 1,400 experienced specialists from oncological practices, municipal clinics and university clinics as well as our partners from the pharmaceutical industry.
Verified activity
Signals from iOMEDICO
2 published signals
Research & Knowledge
iOMEDICO published a new publication in the Interdisciplinary Platform on Benefit Assessment exploring how clinical registry data can help address evidence gaps in AMNOG and the Joint Clinical Assessment.
Reported by iOMEDICO
Research & Knowledge
iOMEDICO published the final results of the REALTRK registry on rare NTRK fusion-positive cancers in JCO Precision Oncology, including 47 adults with advanced solid tumors and 26 patients who received TRK inhibitor therapy.
Reported by iOMEDICO